Navigation Links
Allergy Standards LTD to Attend 2008 American Academy of Allergy, Asthma and Immunology Conference
Date:3/12/2008

DUBLIN, Ireland, March 12 /PRNewswire/ -- Allergy Standards LTD ("ASL"), the internationally recognized third party evaluator of consumer products, today announced its participation at the 2008 American Academy of Allergy, Asthma and Immunology (AAAAI) Conference to be held in Philadelphia, PA March 14th-18th.

"The AAAAI conference is the premier forum for those working and conducting research work in the asthma and allergy spaces," said Dr. John McKeon, CEO of Allergy Standards LTD. "Participating in this prestigious event provides Allergy Standards LTD with the ability to educate physicians regarding how to help their patients make healthy, informed decisions when making everyday purchases for the home."

About Allergy Standards

Allergy Standards LTD is a physician founded, independent, third party tester of products such as pillows, bedding, paints, vacuums, furniture, toys and washing machines. The Company uses information about quality environmental control standards to reduce everyday exposure to asthma and allergy triggers and dangerous toxins. Manufactures such as Dyson, Build-A- Bear Workshop, LG and Hollander work with ASL to scientifically certify products that reduce the likelihood of their triggering an allergic or asthmatic response. With their partner, the Asthma and Allergy Foundation of America (AAFA), ASL has become internationally recognized through its asthma and allergy friendly(R) Certification brand and asthma and allergy friendly(R) Certified products. Certified products are easily identifiable at the point of purchase and are widely available at retailers such as Target, Bed Bath and Beyond, JC Penney, Home Depot and Wal-Mart.


'/>"/>
SOURCE Allergy Standards LTD
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. LPGA Pro, Jill McGill, Encourages Indoor and Outdoor Allergy Sufferers to Challenge Their Course
2. Circassia Initiates Phase II Clinical Study With Novel Anti-Allergy Technology
3. One Year On, ALLERCA Hypoallergenic Cats Bring Sneeze Free Companionship to Allergy and Asthma Sufferers
4. The Food Allergy & Anaphylaxis Network (FAAN) and Verus Pharmaceuticals Work Together to Raise Awareness of Food Allergies
5. AcroMetrix Signs Development and Supply Agreement With Beckman Coulter Inc. for Molecular Quality Control Standards
6. Data Presented on Monogram HIV Tropism Tests at Retrovirus Conference sets New Standards of Assay Sensitivity
7. CNCA Exceeds Standards in Nutritional Supplement Quality, Protects Public
8. Solazyme Selected for National Institute of Standards and Technology Award
9. Kendle Invites You to Attend Its Third Quarter 2007 Earnings Conference Call and Webcast
10. Suntech to Attend Upcoming Investor Conferences and Industry Events
11. Alseres Pharmaceuticals Presents Inosine and Dopamine Transporter (DAT) Blocker Preclinical Data at the American Society for Experimental NeuroTherapeutics (ASENT) Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... SAN DIEGO , Dec. 8, 2016 /PRNewswire/ ... presented demonstrating the role of the Breast Cancer ... stage, ER+ breast cancer are most at-risk for ... therapy. Data include results from three studies advancing ... provide information related to tumor biology and inform ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... SDK that provide essential device-to-computer interconnect using USB or PCI Express, announced the ... support. The FOMD-ACV-A4 is a small, thin, SODIMM-style module that fits a standard ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... data bioInformatics portal. In response to client demand KbioBox developed a sophisticated “3 ... biodesign program. Both are accessible from KBioBox’s new website, https://www.kbiobox.com/ ...
(Date:12/8/2016)... N.J. , Dec. 8, 2016  Soligenix, ... late-stage biopharmaceutical company focused on developing and commercializing ... an unmet medical need, announced today the long-term ... with SGX942 (dusquetide), a first-in-class Innate Defense Regulator ... in head and neck cancer patients undergoing chemoradiation ...
Breaking Biology Technology:
(Date:12/7/2016)... 7, 2016   Avanade is helping Williams ... teams in history, exploit biometric data in order to ... maintain the competitive edge against their rivals after their ... Avanade has worked with Williams during the 2016 ... data (heart rate, breathing rate, temperature and peak acceleration) ...
(Date:12/6/2016)... , Dec. 6, 2016 Securus ... justice technology solutions for public safety, investigation, corrections ... jointly announced today a five (5) year funding ... agreement to expand the rehabilitation and reentry support ... PEP History Established in 2004, the Prison Entrepreneurship ...
(Date:11/30/2016)... , Nov. 30, 2016 Not many of us realize that we spend ... recovery so we need to do it well. Inadequate sleep levels have been found ... pressure, stroke, diabetes, and even cancer. Maybe now is the best time ... could help them to manage their sleep quality? Continue ... ...
Breaking Biology News(10 mins):